ELGX

Endologix IntuiTrak Delivery System Receives Shonin Approval for Marketing in Japan

[at noodls] – IRVINE, Calif., Dec. 31, 2012 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that its distribution partner in Japan, … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboardSee who Endologix is hiring next, click here to view […]

Endologix Comments on Alleged Patent Infringement

[at noodls] – IRVINE, Calif., Dec. 31, 2012 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has become aware that Lifeport … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboardSee who Endologix is hiring next, click here to view […]

Endologix to Participate in Several Upcoming Investor Conferences

[at noodls] – IRVINE, Calif., Nov. 6, 2012 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President and … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboard […]

Endologix to Report Third Quarter 2012 Financial Results on October 25, 2012

[at noodls] – IRVINE, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboard […]

Endologix Settles Patent Litigation With Cook Medical

[at noodls] – IRVINE, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has entered into a comprehensive … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboard […]

Endologix Appoints Charles Love Vice President of Clinical Affairs

[at noodls] – IRVINE, Calif., Oct. 1, 2012 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has appointed Charles Love … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboard […]